Background: More than 10% of the population visit emergency departments (ED) every year. Many of these patients are not up-to-date on routine vaccinations that could prevent future illnesses. The ED could significantly impact these vaccination trends.
T here are now more than 100 million emergency department (ED) visits in the United States per year. More than 10% of Americans visit an ED annually, and many preferentially visit EDs rather than traditional primary care providers. 1 Studies have shown that vaccination in the ED is a cost-effective way to decrease the number of patients who are later admitted to the same hospitals for vaccine-preventable diseases. [2] [3] [4] [5] [6] Despite this, there is evidence that ED patients are rarely immunized when needed. 7 Emergency departments are one of the few settings where the medical establishment has access to large numbers of patients with chronic illnesses and underinsured or uninsured people who do not have the opportunity to be vaccinated in traditional primary care settings. Due to ED overcrowding, many patients have prolonged waiting periods, are willing to use this time to receive immunizations, and accept vaccinations in the ED when offered. [8] [9] [10] The purpose of this study was to evaluate a program to provide influenza (flu) and pneumococcal vaccines to high-risk patients in the ED. The primary hypothesis was that patients would be amenable to an ED-based program that provided appropriate immunizations when they were at high risk for these diseases. The secondary hypotheses were 1) that we could identify barriers that predict those high-risk patients who had not received immunizations before presentation in the ED and 2) that we could identify barriers that predict those high-risk unvaccinated patients unwilling to receive vaccinations in the ED when offered.
METHODS

Study Design
This was a prospective cross-sectional study of patients presenting to the ED at an inner-city Level 1 trauma center. The institutional review board approved the study.
Study Setting and Population
Subjects represented a consecutive sampling of patients during the study period. The hospital census is >60,000 adult ED patient visits per year.
Study Protocol
The study was conducted seven days a week over the three-week period in 2003 between December 1 and December 21. The program was implemented during the hours of 10 AM to 10 PM, which, based on historical data, represented 70% of all patients arriving at the door. The times were split into three 4-hour time blocks and covered by trained bilingual student interviewers. Overall, 100% of the time blocks were covered.
Intervention. All subjects older than 18 years were identified at our triage booth. They were each asked whether they were interested in participating in a study about vaccination. Each subject was asked by a bilingual study associate which language (English or Spanish) he or she would prefer for taking the written survey (the English version of the survey is available as a Data Supplement at http://www.aemj.org/cgi/content/full/j.aem.2006.04.022/ DC1). The Spanish-language survey was translated from English by a bilingual member of our staff. It was then presented to two other members of our staff who spoke the local dialect of Spanish to ensure that the meaning was comparable in both languages. For study purposes, language spoken as a variable was based on whether the subject chose to complete the questionnaire in English or Spanish. Although we are not aware of anyone who consented and was missed, it is possible that this could have occurred if the subject was called into the ED too quickly.
The surveys were presented to the subjects by medical students trained in proper interview technique, knowledge about flu and pneumococcal diseases and vaccines, and giving vaccinations. They were instructed in how to approach subjects in both English and Spanish. The subjects then read and completed the written survey that included information about their risk for flu and pneumococcal disease, their immunization history, and their perceptions of their need for immunization. We checked the medical history through our computerized charting system for all subjects who were unsure about their immunization status. Demographic information was collected on all subjects, including insurance status, age, and gender. Data entry was completed by one individual and then rechecked by a second investigator.
Risk Assessment. Flu risk assessment was based on the Centers for Disease Control and Prevention (CDC) highrisk guidelines. [11] [12] [13] [14] [15] For flu, the high-risk group was defined as age older than 50 years, having a high-risk medical disease, or proximity reasons. High-risk medical diseases for flu included diabetes, lung disease, heart or kidney disease, sickle cell disease, cancer, human immunodeficiency virus or acquired immunodeficiency syndrome, corticosteroid use, or pregnancy during flu season. Proximity reasons to be considered high risk included living with someone older than 65 years or someone who has one of the high-risk medical diseases, living with a child younger than 2 years, being a health care worker, or providing essential community services.
High-risk criteria for pneumococcal disease were also based on CDC guidelines. 15 For pneumococcal disease, high risk was defined to include age older than 65 years, being a Native American or Alaskan Native, and/or having a high-risk medical disease. The high-risk medical diseases related to pneumococcal disease included diabetes; lung disease; heart, kidney, or liver disease; alcoholism; sickle cell disease; cancer; human immunodeficiency virus or acquired immunodeficiency syndrome; splenectomy; spinal fluid leak; or corticosteroid use.
Subjects who were identified as high risk for either disease were offered the appropriate vaccination. Acceptance and refusals were documented. Low-risk patients were not offered vaccination due to the shortage of vaccine.
Data Analysis
Surveyors entered patient data on a standardized data information collection sheet. Descriptive analysis was completed using standard parametric and nonparametric methods. Two-way contingency analysis was completed using chi-square and Spearman correlation coefficients for two subgroups. The first subgroup was all high-risk subjects. The comparison was made between those in this group who were up-to-date and those who were not up-to-date (comparison 1). The second subgroup was all high-risk subjects who were not up-to-date. The comparison was made between those who were offered and were not administered vaccination in the ED and those who were administered vaccination (comparison 2). Separate logistic regression models were used to identify potential barriers associated with being up-todate for vaccination on presentation to the ED and for receiving a vaccination in the ED. Missing values were removed because of the low numbers. The logistic model was based on the smallest comparison subgroup, thus allowing five variables in the model. A univariate p-value <0.1 for either comparison qualified the variable for inclusion in the maximum model. The maximum model was formally assessed for the presence of multicollinearity using a regression eigenanalysis, with a condition number R30 indicative of moderate to severe colinearity as described elsewhere. 16 All data analysis was completed using SPSS 13.0 (SPSS Inc., Chicago, IL) for Windows (Microsoft Inc., Redmond, WA).
RESULTS
A total of 674 patients were enrolled in the study. For the flu vaccine data analysis, 26 cases were excluded for missing values. For the pneumococcal vaccine data analysis, 18 cases were excluded for missing values. Of the 648 subjects included for flu vaccine evaluation, 447 patients (69%) were at high risk for flu. Of the 656 subjects included for pneumococcal vaccine evaluation, 295 (45%) were at high risk for pneumococcal disease.
Seventy-three of the 447 subjects at high risk for flu (16%) were up-to-date at entry into the study. At completion of the program, an additional 296 were administered flu vaccine so that a total of 369 of the 447 high-risk subjects (83%) were vaccinated for flu (difference, 67%; 95% confidence interval [CI] = 61% to 71%). Fifty-four of the 295 subjects at high risk for pneumococcal disease (18%) were up-to-date at entry into the study. At completion of the program, an additional 194 subjects were administered pneumococcal vaccine so that a total of 248 of the 295 high-risk subjects for pneumococcal disease (84%) were vaccinated (difference, 66%; 95% CI = 60% to 72%). Figures 1 (flu) and 2 (pneumococcal disease) show the exact breakdown of all patients in the study. Table 1 shows the demographics of the subjects entered into the study. Results for the 674 subjects are presented for insurance status, age, gender, languages spoken, and perceived need for vaccination. A large portion of our population is uninsured (44%). Although 44% of subjects spoke Spanish, only 88 (13%) completed the survey in Spanish and were considered for the purpose of our study to use Spanish as their primary language. The general population reported a higher perceived need for flu vaccination than for pneumococcal vaccine.
Flu vaccine was considered essential by 76% (n = 512) of the subjects. Of those who thought they should get a flu vaccine, 357 (70%) were correct, based on being at high risk for the flu. Seventy-eight (21%) of the high-risk subjects for flu did not get flu vaccine. Of these, nine said they would get a vaccine later, 18 were given information about flu vaccination, and 14 said they would not get a flu vaccination either now or later. The remainder (37) were not vaccinated because of conditions that might be considered contraindications to vaccination or diseases that precluded vaccination.
Pneumococcal vaccine was considered essential by 41% (n = 274) of the subjects. Of those who thought they should get a pneumococcal vaccine, 154 (56%) were correct, based on being at high risk for pneumococcal disease. Forty-seven high-risk subjects for pneumococcal disease (20%) did not receive pneumococcal vaccine. Of these, ten said they would get a pneumococcal vaccination later, 12 accepted information about pneumococcal vaccine, and four said they would not get a pneumococcal vaccination either now or later. The remainder (21) were not vaccinated because of conditions that might be considered contraindications to vaccination or diseases that precluded vaccination.
Missing values were removed from further analysis because these numbers were very small. Sixteen patients had no gender recorded, and five had no age recorded; all values were present for insurance status and need for vaccination. In addition, the flu group was missing three values for whether or not the subject was up-todate, and there were ten values for risk information missing. This led to 26 total subjects (3.9%) being removed for analysis of flu vaccine barriers and 18 (2.7%) being removed for analysis of pneumococcal vaccine barriers (see Figures 1 and 2) . Figures 1 and 2 show the subjects who were included in the logistic analysis for flu vaccine and pneumococcal vaccine barrier analysis, respectively. Model 1 looked at high-risk subjects and compared those who were up-to-date with those who were not up-to-date (see comparison 1 in Figures 1 and 2 ). Model 2 looked at those high-risk unvaccinated subjects who were offered vaccinations and compared those who received vaccine with those who did not receive vaccine (see comparison 2 in Figures 1 and 2) . Tables 2 and 3 represent bivariable analyses of the variables considered for regression modeling. As can be seen, all variables were significantly different in this analysis except for gender and language used. Based on the model criteria, these two were removed from further analysis. Logistic models for flu vaccine are shown in Table 4 . Maximum condition number for flu model comparison 1 was 7.85 and for flu model comparison 2 was 19.19, indicating that moderate to severe multicollinearity was not present. Models for pneumococcal vaccine are shown in Table 5 . Maximum condition number for comparison 1 was 7.74 and for comparison 2 was 7.78, indicating that moderate to severe multicollinearity was not present.
Barriers to vaccination before presenting to the ED program for both flu and pneumococcal vaccines were no insurance, age younger than 50 years, and a lack of perceived need for vaccination. After being included in the ED program, we found that the only barrier to obtaining vaccine (in the absence of a shortage of vaccine) was that those who perceived they did not require a flu vaccine were significantly less likely to receive a vaccination in the ED setting.
DISCUSSION
Vaccination can be a low-cost, cost-effective, singleevent, and minimal-risk intervention that would potentially reduce the morbidity and mortality associated with a number of vaccine-preventable diseases in the populations that are vulnerable and hard to reach in traditional primary care settings. A recent study from Australia suggests that a hospital-based vaccination program may be more effective than one based in primary care. 17 The expert committee of the Society for Academic Emergency Medicine included only pneumococcal vaccination of patients aged 65 years and older in their list of preventive services that could be delivered in the ED and recommended that such a program be administered when resources were available. 8 An American College Comparison 1 is up-to-date high-risk subjects (n = 73) vs. not up-to-date high-risk subjects (n = 374). Comparison 2 is unvaccinated high-risk subjects who were administered vaccine in the ED (n = 296) vs. unvaccinated high-risk subjects who were not administered vaccine (n = 78). See Figure 1 for further explanation of subject inclusion. Comparison 1 is high-risk subjects who were up-to-date (n = 54) vs. high-risk subjects who were not up-to-date (n = 241) on presentation to the ED.
Comparison 2 is unvaccinated high-risk subjects who were administered (n = 194) vaccine in the ED vs. unvaccinated high-risk subjects who were not administered (n = 47) vaccine. See Figure 2 for further explanation of subject inclusion.
of Emergency Physicians policy statement recommends that ED personnel should consider providing routine immunizations if other sources are not readily available. 18 We found that, before ED presentation, barriers to vaccination included lack of insurance, younger age, and lack of perceived need for vaccination. In our program, we were able to overcome all of these except for perceived need. This suggests that more focused ED educational material could overcome this final barrier as well.
Pneumococcal vaccination in EDs may be a cost-beneficial way to prevent subsequent hospitalization for invasive pneumococcal disease. [2] [3] [4] [5] Influenza vaccination may lead to similar reductions, although the cost and benefits have not been studied. 3, 4, 6, 19, 20 These two vaccines, along with the tetanus booster, have the benefit of conferring their immunity after a single dose, as opposed to the hepatitis and many childhood vaccinations, which require a series of shots.
As overcrowding increases the ED length of stay for patients, patients have more waiting time available in the ED that may be used for other purposes. Only half of ED visits are for urgent or emergent care, and the average time spent in the ED is three hours; therefore, there is ample opportunity to provide preventive health interventions to people who seek care in EDs. Thirteen percent of adults in the United States do not have a regular source of primary care and are significantly less likely to have previously received recommended immunizations. 19 While only about 1% report that EDs are their usual source of care, studies show that a much larger proportion rely on EDs for care. 19, [21] [22] [23] Disparities in immunization coverage are known to exist in the underinsured or uninsured and in racial and ethnic groups. These patients are also more likely to be seen in the ED.
We were not limited by cost, because the interviewers were volunteer medical students. Cost is often a barrier to a successful program. Although a comprehensive investigation of the costs and savings of ED vaccination has not been conducted, a number of studies strongly suggest that vaccination would be cost-saving. 24 Slobodkin et al. estimated that influenza immunization provided in the ED would reduce hospitalizations by 1,000 patients, prevent 300 premature deaths, and save $225 million. They also estimated that ED vaccination of patients against pneumococcal disease would prevent 4,000 premature deaths and save $2 billion. 3 One other study looked at the feasibility of vaccinations in the ED. In the study, patients were vaccinated in a Canadian ED over a four-week period. 25 They looked earlier in the season, before patients were brought up-to date by their primary providers. Our study was performed after we would expect all likely subjects to have been vaccinated. Unlike our study, 35% of patients presenting to the ED in the Canadian study were up-to-date on flu vaccine and 38% were up-to-date on pneumococcal vaccine. This was almost double the background level of vaccinations that we saw in our study. At the end of their study, 70% of the study population was vaccinated for flu compared with 83% in our study, and 76% of the study population was vaccinated for pneumococcal disease compared with 84% in our study. Significantly fewer of our patients were initially vaccinated and significantly more were vaccinated at the end of the study. This is a striking difference between the programs. We attribute these differences to a poorer preventive health system in general and to our use of dedicated medical students as surveyors.
While language is often a barrier, it was not the case in our study. All patients presenting to our ED speak English, Spanish, or both. All of our interviewers were bilingual, thus decreasing the possibility that the Spanish-speaking population would be uncomfortable or left out of the study population.
A unique aspect of this study was the participation of a reasonably large number of Native Americans. Native Americans are automatically at high risk for pneumococcal disease based on CDC recommendations. They represented 82 of the 295 patients at high risk for pneumococcal disease, or almost 30%. The Native Americans were far more likely to have been vaccinated against flu than all other groups, the only significant difference for them.
A number of other barriers have been considered in regard to an ED immunization program. These include lack of staff time in the ED for vaccination and assessment, insufficient ED funding for vaccines, and lack of availability of the vaccines. These barriers ultimately lead to a lack of sustainability of programs to provide these needed preventive care interventions. The use of well-trained medical students in academic centers could help overcome these barriers.
LIMITATIONS
This study covered only a three-week period during the fall and winter season. It was timed to occur after most people who were going to get vaccinated would have had their vaccinations completed. It is possible that if the study period were either earlier or later in the season, the flu vaccine numbers might have changed dramatically. The study did not address the needs of low-risk patients, because the supply of vaccine only permitted the study of high-risk patients at this time. We also did not check the accuracy of self-reported vaccination but only checked on status when the patient was unsure. This is consistent with the results of Macdonald et al., who noted self-report to have a sensitivity in the high 90s and a specificity in the 70s. 26 One limitation to our data was that some important variables were not measured in our survey instrument. Race, education, and socioeconomic variables, which could be confounders, were not recorded during the survey. These could all be barriers to good medical care. We also did not record whether or not the subjects had a primary care physician.
As with other studies, coverage of time for running a preventive program in the ED is difficult. We covered 12 hours of the day that historical data indicated would cover more than 70% of the patients. We may have missed some high-risk patients who arrived very late at night or in the early morning. We also missed a significant group of subjects who refused to take part in the survey, and we do not have data on how this refusal group compared with the entered subjects.
There are many constraints to an ED-based prevention program, including the need for additional resources, training of surveyors, risk management considerations, and system oversight. This study may not be generalizable to nonacademic centers where medical students are not available for primary health care and preventive services to the community. Perhaps an ED program such as this one could be complementary to community-based programs, such as public health care visitors or community health centers.
CONCLUSIONS
On presentation to the ED, fewer than 20% of high-risk subjects are vaccinated for flu and pneumococcal disease. After evaluation and treatment in our ED vaccination program, more than 80% of subjects were up-todate on vaccination. Age, insurance status, and patients' perceived lack of need were the primary barriers for patients who do not get vaccinations before presenting to the ED during the study period. In the ED setting during our study period, the only barrier to administration of vaccine was the subject's perceived lack of need, and this was only significant for flu vaccine. Other than a shortage of vaccine, the only ED barrier to vaccination (perceived need) might be overcome with patient education.
